Safety of Thrombolysis in Stroke Mimics
Author(s) -
Sanne M. Zinkstok,
Stefan T. Engelter,
Henrik Gensicke,
Philippe Lyrer,
Peter A. Ringleb,
Ville Artto,
Jukka Putaala,
Elena Haapaniemi,
Turgut Tatlisumak,
Yaohua Chen,
Didier Leys,
Hakan Sarıkaya,
Patrik Michel,
Céline Odier,
Jörg Berrouschot,
Marcel Arnold,
Mirjam R. Heldner,
Andrea Zini,
Valentina Fioravanti,
Višnja Padjen,
Ljiljana BeslaćBumbaširević,
Alessandro Pezzini,
Yvo B.W.E.M. Roos,
Paul J. Nederkoorn
Publication year - 2013
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.111.000126
Subject(s) - medicine , thrombolysis , stroke (engine) , physical medicine and rehabilitation , surgery , intensive care medicine , cardiology , myocardial infarction , mechanical engineering , engineering
Intravenous thrombolysis for acute ischemic stroke is beneficial within 4.5 hours of symptom onset, but the effect rapidly decreases over time, necessitating quick diagnostic in-hospital work-up. Initial time strain occasionally results in treatment of patients with an alternate diagnosis (stroke mimics). We investigated whether intravenous thrombolysis is safe in these patients.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom